11 February 2026

TGA approves intranasal adrenaline

3 minute read

Timely news, given the current discussion around upholding an interim decision to classify adrenaline-based intranasal preparations as Schedule 3 medicines.

This content is for AHPRA registered professionals only.
Login Join Now

End of content

No more pages to load

Register for a new account

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

Billing Address

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

I agree to the Terms and conditions and privacy policy *

Processing...

TGA approves intranasal adrenaline

New ASCIA advice on infant formula and allergen introduction

Prevalence of food allergies beyond ‘the big 8’

Influenza has come out clawing this summer

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Log in

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover